Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)

Not featured in screeners

Not featured in screeners

Insider activity signals

0 activity signals detected for Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Download results Settings

McCune, Michael Grant Senior Officer of Issuer Officer

Transaction date 6 Feb 2023

Sale

Price

330.86

Quantity 3,486 -7.4%

Value CA$4,122,649

Storey, Annie Director of Issuer Non-Executive Director

Transaction date 8 Aug 2022

Sale

Price

465.91

Quantity 82,894 +49.1%

Value CA$3,062,012

Storey, Annie Director of Issuer Non-Executive Director

Transaction date 7 Jul 2022

Sale

Price

172.45

Quantity 65,045 +15.7%

Value CA$2,793,429

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-02-21	2023-02-06	S Sale	McCune, Michael Grant Senior Officer of Issuer Officer	3,486 -7.4% 330.86 CA$4,122,649	3,486 -7.4%	330.86	CA$4,122,649
2022-08-15	2022-08-08	S Sale	Storey, Annie Director of Issuer Non-Executive Director	82,894 +49.1% 465.91 CA$3,062,012	82,894 +49.1%	465.91	CA$3,062,012
2022-07-13	2022-07-07	S Sale	Storey, Annie Director of Issuer Non-Executive Director	65,045 +15.7% 172.45 CA$2,793,429	65,045 +15.7%	172.45	CA$2,793,429

More insider trading research around Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)